EP2306977
Aðferð og samsetnign til að meðhöndla háþýsting í auga og gláku
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.5.2009EP published:
13.8.2014EP application number:
09754864.8
EP translation filed:
12.9.2014Grant published:
15.10.2014EPO information:
European Patent Register
Max expiry date:
27.5.2029Expiry date:
27.5.2026Next due date:
31.5.2026
Title:
METHOD AND COMPOSITION FOR TREATING OCULAR HYPERTENSION AND GLAUCOMA
Timeline
Today
28.5.2009EP application
13.8.2014EP Publication
12.9.2014Translation submitted
15.10.2014Registration published
27.5.2026Expires
Owner
Name:
Santen Pharmaceutical Co., LtdAddress:
9-19, Shimoshinjo 3-chome Higashiyodogawa-ku, 533-8651, Osaka-shi Osaka, JP
Name:
AGC Inc.Address:
5-1, Marunouchi 1-chome, 100-8405, Tokyo, Chiyoda-ku, JP
Inventor
Name:
REUNAMAKI, TimoAddress:
Tampere, FI
Name:
PELLINEN, PerttiAddress:
Lempaala, FI
Name:
OKSALA, OlliAddress:
Tampere, FI
Name:
LEHMUSSAARI, KariAddress:
Tampere, FI
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
08397513Date:
30.5.2008Country:
EP
Classification
Categories:
A61K 9/08, A61K 47/10, A61K 47/26, A61K 47/18, A61K 31/5575
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 9.4.2015
Expires: 27.5.2016
Payer: Árnason Faktor
Number: 8
Paid: 12.4.2016
Expires: 27.5.2017
Payer: Árnason Faktor
Number: 9
Paid: 10.4.2017
Expires: 27.5.2018
Payer: Árnason Faktor
Number: 10
Paid: 9.4.2018
Expires: 27.5.2019
Payer: Árnason Faktor
Number: 11
Paid: 5.4.2019
Expires: 27.5.2020
Payer: Árnason Faktor
Number: 12
Paid: 7.4.2020
Expires: 27.5.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 8.4.2021
Expires: 27.5.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 5.4.2022
Expires: 27.5.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 12.4.2023
Expires: 27.5.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 9.4.2024
Expires: 27.5.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 9.5.2025
Expires: 27.5.2026
Payer: Árnason Faktor ehf.